Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma
Clinical trial NCT07479628 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07479628
- Sponsor
- Shanghai Chest Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-03-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.